Log in
Diagnostic Radiology · Diagnostic Radiology in Oncology

Radiation therapy of the breast

Glandula mammaria

Diagnostic radiology plays a key role in the detection, staging, and treatment monitoring of breast neoplasms. Magnetic resonance imaging (MRI) is the gold standard for assessing tumor response to therapy and is also essential for monitoring tissue status after radiation or surgical treatment.

MRI timingIdeally performed on days 7–13 of the menstrual cycle
Post-radiation changesTissue contrast enhancement normalizes 3–6 months after irradiation
ScreeningMRI is required in cases of BRCA mutations and after mantle field irradiation
ImplantsMRI is the most accurate method for assessing integrity without contrast
4 min readFor medical studentsUpdated 10.10.2026
Material prepared by WhiteCoat Pro editorial team based on platform study guidesPending instructor review

Impact of radiation therapy and treatment monitoring

Adjuvant radiation therapy effectively reduces the rate of local recurrence by controlling residual disease foci after breast-conserving surgery. However, prior irradiation or surgical intervention significantly complicates image interpretation. Background tissue contrast enhancement normalizes only 3–6 months after the completion of radiation therapy.

Furthermore, a history of irradiation is a major risk factor. In patients who received mantle field radiation therapy (mantle radiotherapy) for lymphoma in their second or third decade of life, the risk of developing breast cancer by age 40–45 reaches 13–20%. Since the sensitivity of standard mammography is low in this group, using MRI is critical for screening.

Dynamic contrast-enhanced CT (DCE-CT) data may also be considered when planning radiation therapy: its parameters serve as a marker of the tumor hypoxic environment, which directly correlates with radiation resistance.

The role of MRI in staging and diagnosis

Contrast-enhanced MRI is the most accurate tool for determining the true size of invasive cancer. The method allows for the detection of occult multifocal lesions in the same breast (about 16% of cases) or additional foci in the contralateral breast (about 4%).

MRI is of particular importance in lobular carcinoma (lobular carcinoma). Due to infiltrative growth associated with the loss of the E-cadherin adhesion molecule, this type of cancer is difficult to measure using ultrasound or mammography. In half of such patients, MRI shows a more extensive lesion than initially suspected.

Any suspicious findings require histological verification. The surgical plan should not be changed until malignancy of the new foci is confirmed. For this, targeted second-look ultrasound (second-look ultrasound) is used. If no ultrasound equivalent is found, the probability of cancer decreases, but MRI-guided biopsy is still indicated if the MRI picture is suspicious.

Controversial points: Despite logical expectations, clinical trials (such as COMICE and MONET) have not proven that preoperative MRI reduces the rate of re-excision or improves long-term outcomes in breast-conserving surgery.

Test your knowledge on the topicTasks from the "Diagnostic Radiology" course bank — instant answers and explanations.

Assessment of response to neoadjuvant chemotherapy (NAC)

NAC is prescribed for locally advanced, triple-negative breast cancer, high-grade tumors, or in the presence of lymph node metastases. MRI is recognized as the gold standard for monitoring response to such therapy.

The method records positive dynamics earlier than other imaging modalities: a decrease in size, lower contrast uptake intensity, or a shift in the enhancement pattern toward a more benign appearance is noted. Successful NAC can downstage the disease (downstage), allowing approximately 59% of women initially threatened with mastectomy to undergo breast-conserving surgery.

Dynamic contrast-enhanced CT (DCE-CT) and nuclear medicine

DCE-CT assesses microvascular changes associated with angiogenesis. Vascular permeability in tumors is typically higher than in healthy tissues. The method is accessible and inexpensive, but is associated with a high radiation dose and cannot always clearly differentiate malignant processes from inflammation due to parameter overlap.

Nuclear medicine methods are based on the uptake of specific isotopes (e.g., 18F-FDG for PET or 99mTc-MIBI). They are used for local staging, searching for occult primary tumors in dense breast tissue, and detecting recurrences, although they have not yet become widespread routine clinical practice.

Breast implant imaging

MRI surpasses ultrasound and mammography in assessing implant integrity, boasting a sensitivity and specificity exceeding 90%. The procedure is performed without contrast (unless malignancy is suspected), in the prone position using a dedicated coil.

In intracapsular rupture, the silicone is contained by the fibrous capsule. On T2-weighted images, this manifests as specific signs:

  • The linguini sign (linguini sign) or wavy line sign — a floating elastomer shell.
  • The key-hole sign (key-hole).
  • The salad oil sign (salad oil sign) — bright droplets of water-like material.

Extracapsular rupture, where silicone extends beyond the capsule, can also be successfully diagnosed using ultrasound (visualizing free silicone or granulomas).

How to memorize

To remember the MRI features of an intracapsular implant rupture, imagine an Italian dinner: the wavy shell floats in the silicone like linguini pasta (linguini sign), and a drop of salad oil (salad oil sign) shines nearby.

Class and exam questions

When is the best time to perform a breast MRI?

The optimal timing is the second week of the menstrual cycle (days 7–13), as background contrast enhancement by normal glandular tissue is minimal during this period.

How soon after radiation therapy can an MRI be done?

Image interpretation is complicated by post-radiation changes. Normalization of contrast enhancement occurs 3–6 months after the completion of radiation therapy.

What to do if a suspicious lesion is found on MRI, but is not visible on ultrasound?

The absence of an ultrasound equivalent reduces the risk of malignancy, but does not rule it out. In such cases, an MRI-guided biopsy is indicated.

Is contrast needed for a breast implant MRI?

If there is no suspicion of a malignant process and the sole purpose of the study is to assess implant integrity, a contrast agent is not required.

Something unclear? Ask the AIThe AI tutor has reviewed the material on "Breast Radiation Therapy" and will explain it in simple terms.

What else to study on this topic

  • Application of shear-wave elastography to increase ultrasound specificity
  • Use of the ACR BI-RADS standardization system
  • Efficacy of digital breast tomosynthesis (DBT) and contrast-enhanced spectral mammography (CESM)
  • Preoperative lesion localization and the impact of breast density on diagnostics
  • Interventional radiology: vacuum-assisted biopsy (VAB) and percutaneous excision

Master the entire topic in the "Diagnostic Radiology" course

This is a summary. The course covers everything tested in classes and exams.

  • Complete study guide on "Breast Radiation Therapy" and 2,199 other subject pages
  • Assignments and quizzes after every topic — just like in a colloquium
  • AI tutor answers questions on the topic anytime
  • 10 video lessons on the subject

Other topics in the "Diagnostic Radiology in Oncology" section

Entire section "Diagnostic Radiology in Oncology"

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.